These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27792051)

  • 1. Advances and controversies in the management of medullary thyroid carcinoma.
    Maia AL; Wajner SM; Vargas CV
    Curr Opin Oncol; 2017 Jan; 29(1):25-32. PubMed ID: 27792051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.
    Ceolin L; Duval MADS; Benini AF; Ferreira CV; Maia AL
    Endocr Relat Cancer; 2019 Aug; 26(9):R499-R518. PubMed ID: 31252403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
    Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
    Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
    Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid cancer: a promising model for targeted therapy.
    Torino F; Paragliola RM; Barnabei A; Corsello SM
    Curr Mol Med; 2010 Oct; 10(7):608-25. PubMed ID: 20712590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of medullary thyroid cancer.
    Ball DW
    Minerva Endocrinol; 2011 Mar; 36(1):87-98. PubMed ID: 21460789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hereditary medullary thyroid carcinoma.
    Pappa T; Alevizaki M
    Endocrine; 2016 Jul; 53(1):7-17. PubMed ID: 26839093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.
    Santarpia L; Ye L; Gagel RF
    J Intern Med; 2009 Jul; 266(1):99-113. PubMed ID: 19522829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma.
    Moley JF
    Curr Treat Options Oncol; 2003 Aug; 4(4):339-47. PubMed ID: 12943614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid cancer--current treatment strategy, novel therapies and perspectives for the future.
    Sugawara M; Ly T; Hershman JM
    Horm Cancer; 2012 Dec; 3(5-6):218-26. PubMed ID: 23011723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinoma.
    Almeida MQ; Hoff AO
    Curr Opin Oncol; 2012 May; 24(3):229-34. PubMed ID: 22343387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vandetanib and the management of advanced medullary thyroid cancer.
    Campbell MJ; Seib CD; Gosnell J
    Curr Opin Oncol; 2013 Jan; 25(1):39-43. PubMed ID: 23202050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary thyroid carcinoma and biomarkers: past, present and future.
    van Veelen W; de Groot JW; Acton DS; Hofstra RM; Höppener JW; Links TP; Lips CJ
    J Intern Med; 2009 Jul; 266(1):126-40. PubMed ID: 19522831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting RET receptor tyrosine kinase activation in cancer.
    Phay JE; Shah MH
    Clin Cancer Res; 2010 Dec; 16(24):5936-41. PubMed ID: 20930041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid cancer: therapeutic targets and molecular markers.
    Ball DW
    Curr Opin Oncol; 2007 Jan; 19(1):18-23. PubMed ID: 17133107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of medullary thyroid carcinoma.
    Massoll N; Mazzaferri EL
    Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary thyroid cancer: monitoring and therapy.
    Ball DW
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):823-37, viii. PubMed ID: 17673130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer.
    Yun KM; Cohen EEW
    JCO Oncol Pract; 2024 Jul; 20(7):899-906. PubMed ID: 38452309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Guidelines for Management of Medullary Thyroid Carcinoma.
    Kim M; Kim BH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):514-524. PubMed ID: 34154310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapeutic approaches for medullary thyroid carcinoma treatment.
    Drosten M; Pützer BM
    J Mol Med (Berl); 2003 Jul; 81(7):411-9. PubMed ID: 12811413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.